Latest fiscal year 2026 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2026, Kewaunee Scientific Corporation reported revenue of $282M, up 17.3% year over year. Operating margin was 5.9% and net margin 3.4%, on a free-cash-flow margin of 5.2% with capital expenditure at 1.4% of revenue. Every figure is computed directly from KEQU's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2026 | $282M | 5.9% | 3.4% |
| FY2025 | $240M | 7.4% | 4.7% |
| FY2024 | $204M | 9.0% | 9.2% |
| FY2023 | $219M | 2.4% | 0.3% |
| FY2022 | $169M | -1.5% | -3.6% |
How does KEQU compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.